TMCnet News

Foundation Medicine to Webcast Investor & Analyst Day
[August 31, 2015]

Foundation Medicine to Webcast Investor & Analyst Day


Foundation Medicine, Inc. (NASDAQ:FMI) today announced that it will provide a live video webcast and conference call for its Investor & Analyst Day on September 15, 2015. At the event, members of the Foundation Medicine management team will discuss the company's five-year strategic vision for transforming cancer care and the significance of molecular information as a driver of the company's future growth and value.

Investor & Analyst Day Webcast and Conference Call Details





Date:     Tuesday, September 15, 2015
Time: 1:00-4:30p.m. ET
Webcast:

The video webcast and slide presentation accompanying the conference call can be accessed at www.investors.foundationmedicine.com.

Telephone: Domestic callers, dial 877-633-4016
International callers, dial 914-495-8535
Access code for both domestic and international callers: 23905461

Archives of the video and audio webcasts will be available in the investors section of the company's website at investors.foundationmedicine.com. The replays will be available shortly after the conclusion of the event and will be archived on the company's website following the call.

About Foundation Medicine

Foundation Medicine (NASDAQ:FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (News - Alert) (@FoundationATCG).

Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the information to be presented by Foundation Medicine and the ability of molecular information to drive growth and value for Foundation Medicine. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks described under the caption "Risk Factors" in Foundation Medicine's Quarterly Report on Form 10-Q for the three months ended June 30, 2015, which is on file with the Securities and Exchange Commission, as well as other risks detailed in subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Foundation Medicine undertakes no duty to update this information unless required by law.


[ Back To TMCnet.com's Homepage ]